[HTML][HTML] Prognostic significance of MTOR pathway component expression in neuroendocrine tumors
ZR Qian, M Ter-Minassian, JA Chan… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
ZR Qian, M Ter-Minassian, JA Chan, Y Imamura, SM Hooshmand, A Kuchiba, T Morikawa…
Journal of clinical oncology, 2013•ncbi.nlm.nih.govPurpose Clinical studies have implicated the mechanistic target of rapamycin
(serine/threonine kinase; MTOR) pathway in the regulation of neuroendocrine tumor (NET)
growth. We explored whether expression of MTOR pathway components has prognostic
significance in NET patients.
(serine/threonine kinase; MTOR) pathway in the regulation of neuroendocrine tumor (NET)
growth. We explored whether expression of MTOR pathway components has prognostic
significance in NET patients.
Abstract
Purpose
Clinical studies have implicated the mechanistic target of rapamycin (serine/threonine kinase; MTOR) pathway in the regulation of neuroendocrine tumor (NET) growth. We explored whether expression of MTOR pathway components has prognostic significance in NET patients.
ncbi.nlm.nih.gov